Compare Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK) vs Upwork Inc (UPWK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) vs Upwork Inc — how do they compare? Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) trades at $18.68 (market cap $58.74B), while Upwork Inc trades at $8.65 (market cap $1.07B). The key difference: Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) is far larger — about 54.9× Upwork Inc's market cap, and Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) pays a 3.33% dividend while Upwork Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) for 1 Days and Upwork Inc for 38 Days on average.
| TAK | UPWK | |
|---|---|---|
Market Cap | $58.74B | $1.07B |
Volume | 3,110,994 | 2,574,130 |
Sector | Health | Industrials |
52-Week High | $19.05 | $22.11 |
52-Week Low | $13.23 | $7.84 |
Typical Hold Time | 1 Days | 38 Days |
Enterprise Value | $86.65B | $833.01M |
Dividend Yield | 3.33% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Upwork (UPWK) trades at $8.60, up 2.38% today, with a bearish technical signal despite recent earnings beat. The stock shows strong fundamentals with 77.21% gross margins and 12.93% net income margin, though revenue growth has stalled at $788M in 2025. Recent insider selling and ongoing securities fraud investigations create headwinds, while institutional buying from Bank of America provides some support. Technical indicators show resistance at $9 and support at $8.
The stock presents a mixed outlook with attractive valuation metrics (P/E 10.99, P/S 1.48) but faces significant AI disruption risks and declining active clients. Analyst consensus leans bullish with $9.64 price target, though near-term challenges from weak guidance and legal scrutiny may limit upside potential.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)
Takeda is a Japanese pharmaceutical company developing medicines across areas including gastrointestinal disease, rare diseases, neuroscience, oncology, and plasma-derived therapies.
Read more on TAK →About Upwork Inc
Upwork Inc is a United States-based company that operates an online marketplace that enables businesses to find and work with highly-skilled independent professionals. The develops platform for hiring and freelancing purposes. Its products offering include Upwork Basic, Upwork Plus, Upwork Business, Upwork Enterprise, and Upwork Payroll. The business generates revenue from Talent and Clients across the USA, India, the Philippines and the rest of the world. Substantial income is derived from providing services to Clients.
Read more on UPWK →
